Evaluation of the Efficacy and Safety of LevoCept
Public ClinicalTrials.gov record NCT02882191. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception
Study identification
- NCT ID
- NCT02882191
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sebela Women's Health Inc.
- Industry
- Enrollment
- 279 participants
Conditions and interventions
Conditions
Interventions
- LevoCept Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2016
- Primary completion
- Jul 16, 2018
- Completion
- Nov 11, 2020
- Last update posted
- Apr 22, 2026
2016 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Essential Access Health-Berkeley | Berkeley | California | 94710 | — |
| Essential Access Health-Los Angeles | Los Angeles | California | 90010 | — |
| University of California Davis Health System Department of Obstetrics and Gynecology | Sacramento | California | 95817 | — |
| University Of Colorado Department of Obstetrics & Gyncology | Aurora | Colorado | 80045 | — |
| Healthcare Clinical Data, Inc. | North Miami | Florida | 33161 | — |
| Emory University School of Medicine Gynecology/Obstetrics | Atlanta | Georgia | 30322 | — |
| Kapiolani Medical Center for Women and Children | Honolulu | Hawaii | 96826 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| University of Cincinnati Physicians Company, Inc | Cincinnati | Ohio | 45267 | — |
| Ohio State University | Columbus | Ohio | 43209 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Clinical Research of Philadelphia, LLC | Philadelphia | Pennsylvania | 19114 | — |
| Advanced Research Associates | Corpus Christi | Texas | 78414 | — |
| University of Utah Healthcare Health Sciences Center | Salt Lake City | Utah | 84132 | — |
| Seattle Women's: Health, Research, Gynecology | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02882191, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02882191 live on ClinicalTrials.gov.